Day 1 of the metabolic medicine meeting covered prediabetes, newer GLP-1 drugs, bariatric surgery debates and where diabetes meets cancer.
Recap by typeshit. Post by @andalusiaconferences on Instagram.
German researchers made synthetic versions of peptides from axolotl skin mucus, and some slowed the growth of MRSA, the drug-resistant bacteria.
10:45
The nutrition and exercise graduate walks through her food picks for people on retatrutide, aimed at holding onto muscle during weight loss.
Experts say holding on to weight loss after quitting a GLP-1 is possible and walk through the habits they recommend for the transition.
The study of over 87,000 matched patients 65 and up also found 28% fewer liver decompensation events, but no drop in heart attack or stroke and more osteoporosis diagnoses.
PharmExec says incretin drugs showed up across heart failure, kidney disease, AF and prevention sessions, framed as heart therapies rather than just weight drugs.
UMB posted a recorded session on its YouTube channel covering how GLP-1 medicines work, plus their benefits and risks.
Loading…